Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer;Cardiovascular;Adverse Events”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07299812
What this trial is testing

BRAVE-HEART: Breast Cancer Radiotherapy Using Active Breathing Coordinator to aVoid Exposure of HEART

Who this might be right for
Breast CancerRadiotherapy
Fondazione IRCCS Policlinico San Matteo di Pavia 400
Not applicableLooking for participantsNCT07663357
What this trial is testing

Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity.

Who this might be right for
Cardiotoxicity
Beneficência Portuguesa de São Paulo 1,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT07728188
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
AbbVie 520
Not applicableStudy completedNCT04790266
What this trial is testing

Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer Patients

Who this might be right for
Cardiotoxicity
Oncology Institute of Southern Switzerland 150
Not applicableStudy completedNCT04586894
What this trial is testing

Adverse Myocardial and Vascular Side Effects of Immune Checkpoint Inhibitors

Who this might be right for
CancerImmune DefectCardiovascular Abnormalities
Assistance Publique - Hôpitaux de Paris 50
Post-approval studies (Phase 4)Looking for participantsNCT05465031
What this trial is testing

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Who this might be right for
Breast CancerNeoplasm, BreastBreast Diseases+10 more
Silesian Centre for Heart Diseases 600
Early research (Phase 1)Study completedNCT04023110
What this trial is testing

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

Who this might be right for
CardiotoxicityRisk Factor, CardiovascularToxicity Due to Chemotherapy+3 more
Abramson Cancer Center at Penn Medicine 68
Not applicableUnknownNCT04046315
What this trial is testing

Early Detection of Cardiac Damage With CMR in Women With Breast Cancer

Who this might be right for
CardiotoxicityBreast CancerChemotherapy Induced Systolic Dysfunction
Radboud University Medical Center 55
Not applicableStudy completedNCT04361240
What this trial is testing

Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study

Who this might be right for
Breast CancerCardiotoxicity
Abramson Cancer Center at Penn Medicine 172
Not applicableStudy completedNCT05130489
What this trial is testing

CAR T Cell Therapy Related Cardiovascular Outcomes

Who this might be right for
Cardiovascular DiseasesB-cell Acute Lymphoblastic LeukemiaB-cell Lymphoma Refractory+5 more
University College London Hospitals 150
Not applicableLooking for participantsNCT06151730
What this trial is testing

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

Who this might be right for
Chronic Lymphocytic LeukemiaHematopoietic and Lymphoid System NeoplasmMantle Cell Lymphoma+2 more
Mayo Clinic 100
Not applicableLooking for participantsNCT03720613
What this trial is testing

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

Who this might be right for
Opioid-induced Constipation
BioDelivery Sciences International 34,532
Not applicableLooking for participantsNCT05406635
What this trial is testing

Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer

Who this might be right for
CardiotoxicityHER2-positive Breast Cancer
Odense University Hospital 220
Large-scale testing (Phase 3)UnknownNCT05728632
What this trial is testing

Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines

Who this might be right for
Breast CancerLymphoma, Large B-Cell, DiffuseCardiotoxicity+2 more
Giulio Stefanini 80
Large-scale testing (Phase 3)UnknownNCT04030546
What this trial is testing

Ivabradine to Prevent Anthracycline-induced Cardiotoxicity

Who this might be right for
Patients With Cancer
Vilnius University 128
Not applicableStudy completedNCT05676606
What this trial is testing

Cardiotoxicity Monitoring With Single-lead Electrocardiogram

Who this might be right for
Cardiotoxicity
I.M. Sechenov First Moscow State Medical University 120
Not applicableEnded earlyNCT05699915
What this trial is testing

Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors

Who this might be right for
CancerImmune-related Adverse EventCardiac Abnormalities, Variable+4 more
Algemeen Ziekenhuis Maria Middelares 105
Testing effectiveness (Phase 2)Study completedNCT06888505
What this trial is testing

Dapagliflozin to Prevent Anthracycline-Induced Cardiotoxicity

Who this might be right for
Anthracyclines-Induced CardiotoxicityCardiotoxicity
Hawler Medical University 94
Testing effectiveness (Phase 2)Study completedNCT00004132
What this trial is testing

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+3 more
Jonsson Comprehensive Cancer Center
Not applicableUnknownNCT04092309
What this trial is testing

Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation

Who this might be right for
Hematopoietic Stem Cell TransplantationCardiotoxicity
University of Athens 90
Next Page